We further studied the mechanism of enhanced cytotoxicity induced by the combination therapy with attention to the alteration of Bcl-2 family proteins, because pro- and anti-apoptotic Bcl-2 family proteins dictate the ultimate sensitivity or resistance of cancer cells to various apoptotic stimuli (28). The gene discussed is BCL2; the disease is cancer.